Jan 27, 2020 / 12:00PM GMT
Operator
Ladies and gentlemen, good day, and welcome to Torrent Pharmaceuticals Limited Q3 FY '20 Earnings Conference Call. We have with us on the call today, Mr. Sanjay Gupta, Executive Director, International Business; Mr. Sudhir Menon, Chief Financial Officer; and Mr. Aman Mehta, Chief Marketing Officer, India Business. (Operator Instructions) Please note that this conference is being recorded. I now hand conference over to Mr. Sanjay Gupta. Thank you, and over to you, sir.
Sanjay Gupta - Torrent Pharmaceuticals Limited - Executive Director of International Business
Thank you, Stanton. Good evening, everyone, and welcome to our Q3 FY '20 earnings call. I will take you through some of our key financial highlights of Q3 and make some comments on our key markets. .
Q3 revenues were INR 1,966 crore, down by 4% on a year-on-year basis. Q3 revenues of previous year, including -- included onetime patent-related settlement income. Adjusted for this, Q3 revenue is down by 1%. EBITDA was at INR 591 crore, up by 6% on a year-on-year basis. Again, adjusted for onetime
Q3 2020 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot